|
77
|
279
|
2vwuA |
Ephb4 kinase domain inhibitor complex |
|
78
|
263
|
2w1gA |
Structure determination of aurora kinase in complex with inhibitor |
|
81
|
298
|
2vtpA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
78
|
298
|
2vtaA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
73
|
263
|
2w1eA |
Structure determination of aurora kinase in complex with inhibitor |
|
86
|
281
|
2vx1A |
Ephb4 kinase domain inhibitor complex |
|
78
|
298
|
2vtiA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
84
|
298
|
2vtlA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
75
|
298
|
2vtsA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
88
|
301
|
2w0jA |
Crystal structure of chk2 in complex with nsc 109555, a specific inhibitor |
|
78
|
280
|
2vwvA |
Ephb4 kinase domain inhibitor complex |
|
79
|
298
|
2vtnA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
77
|
263
|
2w1cA |
Structure determination of aurora kinase in complex with inhibitor |
|
105
|
337
|
2vo3A |
Structure of pka-pkb chimera complexed with c-(4-(4-chlorophenyl)-1-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine |
|
79
|
281
|
2vx0A |
Ephb4 kinase domain inhibitor complex |
|
78
|
298
|
2vtoA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
72
|
263
|
2w1fA |
Structure determination of aurora kinase in complex with inhibitor |
|
105
|
337
|
2vnyA |
Structure of pka-pkb chimera complexed with (1-(9h-purin-6-yl) piperidin-4-yl)amine |
|
76
|
298
|
2w05A |
Structure of cdk2 in complex with an imidazolyl pyrimidine, compound 5b |
|
102
|
329
|
2vuwA |
Structure of human haspin kinase domain |
|
79
|
298
|
2vu3A |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
167
|
530
|
2vwbA |
Structure of the archaeal kae1-bud32 fusion protein mj1130: a model for the eukaryotic ekc-keops subcomplex involved in transcription and telomere homeostasis. |
|
77
|
279
|
2vwwA |
Ephb4 kinase domain inhibitor complex |
|
82
|
298
|
2vtrA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
75
|
298
|
2vttA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
78
|
263
|
2w1dA |
Structure determination of aurora kinase in complex with inhibitor |
|
76
|
298
|
2w06A |
Structure of cdk2 in complex with an imidazolyl pyrimidine, compound 5c |
|
84
|
281
|
2vwyA |
Ephb4 kinase domain inhibitor complex |
|
59
|
279
|
2vwiA |
Structure of the osr1 kinase, a hypertension drug target |
|
78
|
298
|
2vv9A |
Cdk2 in complex with an imidazole piperazine |
|
114
|
363
|
2w1zA |
Rop2 from toxoplasma gondii: a virulence factor with a protein- kinase fold and no enzymatic activity. |
|
87
|
269
|
2vrxA |
Structure of aurora b kinase in complex with zm447439 |
|
126
|
347
|
2vx3A |
Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1a |
|
84
|
281
|
2vwzA |
Ephb4 kinase domain inhibitor complex |
|
89
|
269
|
2vgoA |
Crystal structure of aurora b kinase in complex with reversine inhibitor |
|
107
|
337
|
2vo7A |
Structure of pka complexed with 4-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3- d)pyrimidin-4-yl)piperidin-4-ylamine |
|
105
|
335
|
2vagA |
Crystal structure of di-phosphorylated human clk1 in complex with a novel substituted indole inhibitor |
|
108
|
343
|
2vo0A |
Structure of pka-pkb chimera complexed with c-(4-(4-chlorophenyl)-1-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine |
|
110
|
338
|
2vo6A |
Structure of pka-pkb chimera complexed with 4-(4-chlorobenzyl)-1-(7h- pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-ylamine |
|
106
|
301
|
2vn9A |
Crystal structure of human calcium calmodulin dependent protein kinase ii delta isoform 1, camkd |
|
106
|
337
|
2vnwA |
Structure of pka-pkb chimera complexed with (1-(9h-purin-6-yl) piperidin-4-yl)methanamine |
|
109
|
406
|
2vd5A |
Structure of human myotonic dystrophy protein kinase in complex with the bisindoylmaleide inhibitor bim viii |
|
108
|
336
|
2uzvA |
Pka structures of indazole-pyridine series of akt inhibitors |
|
76
|
296
|
2uzoA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
109
|
337
|
2uw7A |
Structure of pka-pkb chimera complexed with 4-(4-chloro-phenyl)-4-(4- (1h-pyrazol-4-yl)-phenyl)-piperidine |
|
90
|
399
|
2v55A |
Mechanism of multi-site phosphorylation from a rock-i:rhoe complex structure |
|
111
|
336
|
2uztA |
Pka structures of akt, indazole-pyridine inhibitors |
|
88
|
296
|
2uzdA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
83
|
285
|
2v5qA |
Crystal structure of wild-type plk-1 kinase domain in complex with a selective darpin |
|
75
|
298
|
2uznA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
